MedTwenty

MHRA and West Midlands Police seize fake weight loss pens worth about £2m in Birmingham raid

More than 12,000 counterfeit retatrutide and tirzepatide pens were seized on 14 October, the MHRA said, along with packaging for around 30,000 more products.

MedTwenty Editorial··4 min read

Share
A close-up of medical injection pens and pharmaceutical packaging arranged on a table beside a stack of banknotes.
A close-up of medical injection pens and pharmaceutical packaging arranged on a table beside a stack of banknotes.

The Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police seized counterfeit weight loss medicines worth approximately £2 million in a raid on an industrial unit in Birmingham on 14 October, the regulator said in a press release published on 15 October 2026.

According to the MHRA, officers recovered more than 12,000 fake retatrutide and tirzepatide pens. They also found packaging for around 30,000 further products. The release does not say whether anyone was arrested in connection with this raid.

Tim Duffield, Head Intelligence at the MHRA's Criminal Enforcement Unit, said the agency is targeting organised criminal gangs whose illegal trade in unauthorised medicines puts people at risk of serious harm. He described the site as a "filthy warehouse on an industrial estate". He said the products have not been assessed for safety, quality or effectiveness, and that there is no guarantee of what they contain or whether they are contaminated with harmful substances.

The MHRA also stated that retatrutide is not authorised for use in the UK. It said products sold as retatrutide outside legitimate clinical trials are being supplied illegally and could pose serious risks to public health.

A series of operations

The MHRA described the October raid as the latest in a series of operations that has removed tens of thousands of doses of unauthorised GLP-1 weight loss medicines from circulation. It listed three earlier cases:

- **October 2025:** the agency dismantled what it called the first illicit weight-loss medicine production facility discovered in the UK. It seized 5,000 unauthorised retatrutide and tirzepatide pens, thousands of empty pens and raw chemical ingredients. Together, the finished products and ingredients represented the potential for tens of thousands of doses. - **February 2026:** around 2,000 doses of unauthorised weight-loss medicines awaiting dispatch were seized, along with manufacturing equipment, suspected pharmaceutical ingredients, packaging and commercial vehicles. - **May 2026:** two people were arrested after a raid on a country estate believed to have been used to manufacture, assemble and distribute unlicensed weight-loss medicines. Around 12,000 doses were recovered, together with packaging materials and suspected pharmaceutical substances.

The MHRA urged people to avoid buying weight-loss medicines from unregulated sources. It said anyone considering GLP-1 treatment should speak to a healthcare professional and obtain medicines only from a registered pharmacy against a valid prescription. People who suspect a side effect from a medicine are encouraged to talk to a doctor, pharmacist or nurse and report it through the MHRA Yellow Card scheme.

The Criminal Enforcement Unit is the MHRA's in-house law enforcement function. The agency said it uses tools including intelligence analysis, online disruption, covert techniques and asset recovery, and works with police and law enforcement agencies in the UK and overseas.

Why it matters

The MHRA's account points to repeated enforcement action against illicit GLP-1 supply, including a production facility and large volumes of packaging. That could add to regulatory and reputational pressure on unregulated online sellers, and it is likely to reinforce the case for prescribing and dispensing only through registered pharmacies. Pharmacies, clinical providers and NHS buyers may want to watch how the regulator positions legitimate supply against the illegal market.

Source: MHRA